MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial.

Introduction: An MRI audit substudy was conducted in patients who underwent an MRI prior to treatment in Australia and New Zealand as part of the PETACC-6 trial in locally advanced rectal cancer.

Methods: A total of 82 patients from 15 centres had rectal MRI scans reviewed for technique, data included in reports and comparison of reports with blinded central reporting by two experienced radiologists.

Results: In total, 82% performed minimum T2 sagittal and T2 axial oblique sequences.